Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2i Add-on in Type 2 Diabetes
NCT06268977Phase 4Completed
- Sponsor
- Assiut University
- Start
- Apr 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Assiut University. Primary endpoints: Hemoglobin A1c at 6 months and Controlled Attenuation Parameter at 6 months. Started Apr 2025; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06268977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06268977.